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Background:Notified cases of hepatitis E have 
increased 40-fold in the past 10 years in Germany. Food 
safety is a major concern as hepatitis E virus (HEV) RNA 
has been detected in ready-to-eat retail-level food 
products. The objective of this case–control study was 
to assess risk factors for autochthonous symptomatic 
hepatitis E and explore reasons for delays in diagno-
sis.  Methods:  Demographic, clinical and exposure 
data from notified hepatitis E cases and individually 
matched population controls were collected in semi-
standardised telephone interviews. Conditional logis-
tic regression analysis was used to calculate matched 
odds ratios (mOR) and population attributable frac-
tions (PAF). Results: In total, 270 cases and 1,159 con-
trols were included (mean age 53 years, 61% men in 
both groups). Associated with disease were: consump-
tion of undercooked pork liver, pork, wild boar meat, 
frankfurters, liver sausage and raw vegetables; con-
tact with waste water (occupational) and various host 
factors (mORs between 1.9 and 34.1, p value < 0.03). 
PAF for frankfurters and liver sausage were 17.6%, 
and 23.6%, respectively. There were statistically sig-
nificant differences in the clinical presentation and 
hospitalisation proportion of acute hepatitis E in men 
and women. Diagnosis was preceded by more invasive 
procedures in 29.2% of patients, suggesting that hep-
atitis E was not immediately considered as a common 
differential diagnosis.  Conclusions:  Our study sug-
gests that there are indeed sex-specific differences in 
disease development and lends important epidemio-
logical evidence to specific ready-to-eat pork prod-
ucts as a major source for autochthonous hepatitis E. 
A review of existing consumer recommendations and 
production methods may be indicated.
Introduction 
Hepatitis E in western and central Europe is predomi-
nantly a zoonosis caused by infection with genotype 3 
hepatitis E virus (HEV). Domestic pigs and wild boars 
have been identified as the main reservoir animals. 
Consumption of raw or undercooked meat, offal and 
meat products have been implicated as risk factors 
for hepatitis E in humans [1-6]. However, several other 
routes of transmission have been demonstrated or sug-
gested: e.g. consumption of shellfish, receiving blood 
products or transplants from an infected donor, con-
tact with infected animals or contaminated water [7-11]. 
Infection is most often asymptomatic, with clinical 
hepatitis more commonly reported among men over 50 
years of age or persons with pre-existing liver disease, 
suggesting that host factors play an important role [12].
The relative importance of the various transmission 
routes and host factors remains unknown. Studies 
involving larger samples of clinical cases and adequate 
control persons are lacking and results on alimentary 
risk factors in particular are not easily transferrable due 
to differences in alimentary habits between countries.
In Germany, hepatitis E is a notifiable disease accord-
ing to the Protection against Infection Act of 2001 [13], 
and the number of notified hepatitis E cases (symp-
tomatic patient with laboratory confirmation) has 
increased 40-fold in the past 10 years. Of the 2,943 
cases notified in 2017, 57% were in men, 75% in the 
age group 40–79 years and 93% in persons with no 
travel history [14]. Seroprevalence and seroincidence 
were estimated at 16.8% and 3.9 infections per 1,000 
population per year, respectively, indicating that HEV 
is highly endemic in Germany [15]. The increase in 
notified cases in recent years is likely attributable to 
an increasing awareness of the disease, indicated by 
a stable or slightly decreasing seroprevalence in the 
German adult population [16]. Thus, the unbroken 
trend towards higher annual case numbers suggests 
that hepatitis E is still underdiagnosed. Food safety is 
a concern as cooking temperatures of 71 °C for 20 min 
are required to fully inactivate the virus [17] and HEV 
RNA has been detected in ready-to-eat food products, 
including raw sausage and liver sausage at retail level 
[18].
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Our objectives were to identify risk factors for autoch-
thonous hepatitis E infections in Germany, and to 
discover reasons for delays in diagnosing hepatitis 




We conducted a country-wide case-control study 
among hepatitis E cases aged 18 years or older notified 
between January 2012 and January 2014 and matching 
controls. All subjects were enrolled after obtaining 
informed consent. The study was approved by the eth-
ics committee of the Charité university hospital, Berlin 
and the Federal Commissioner for Data Protection and 
Freedom of Information.
Hepatitis E patients were recruited by local health 
departments during their routine case investigations. 
If informed consent was provided, the patient’s contact 
data was faxed to the Robert Koch Institute (RKI) so 
that a telephone interview could be conducted. A case 
was defined as a person notified to the local health 
department during the study period with a laboratory-
confirmed HEV-infection (IgM or PCR positive) pre-
senting with at least one of the following symptoms: 
fever, jaundice or abdominal pain. Case-patients were 
excluded from data analysis if the date of symptom 
onset was unknown or if within 2 months before onset 
of symptoms they had travelled within Europe for more 
than 14 days or for any duration outside Europe.
We aimed to match each case-patient with four con-
trol participants of the same sex, age group (18–34, 
35–49, 50–69 and ≥ 70 years) and post code. The con-
trol participants were recruited using a database of 
publicly available telephone numbers (mobiles and 
landlines) with known post code. Interviewers asked to 
speak to a respondent within the household matching 
the respective case criteria. If no household member 
with the sought-after criteria was available the call was 
ended and additional telephone numbers were dialled 
until quota requirements were met.
Data collection
Cases and controls were interviewed by trained study 
personnel via telephone using a standardised question-
naire. The questionnaire was created after a literature 
review and inquired about known risk factors for hepa-
titis E with a focus on alimentary exposures (e.g. meat 
and meat products or following a specific diet) but also 
included environmental exposures (contact with ani-
mals or sewage), person-to-person contact and host 
factors such as pre-existing conditions, alcohol con-
sumption and prescription and over-the-counter medi-
cines, course of disease, diagnostics and symptoms.
The telephone interview of the control persons resem-
bled the interview for case-patients (except diagnos-
tics, disease course and symptoms). Questions about 
possible exposures referred to the 2 months before 
disease onset (case-patients) or before interview 
(controls).
Data analysis
Hypotheses regarding differences between groups 
were tested using chi-squared or Wilcoxon rank-sum 
test. To investigate risk factors for autochthonous 
hepatitis E, univariable analysis including a total of 114 
variables was conducted by computing matched odds 
ratios (mOR) and 95% confidence intervals (CIs) using 
the Mantel-Haenszel method implemented in STATA’s 
mhodds command. We calculated the number of days 
between the date of onset, the date of the first visit to 
a physician, the date of blood sampling and the date of 
diagnosis as reported by the case in order to discover 
reasons for delayed diagnoses.
Variables with an adjusted odds ratio (aOR) > 1 and a 
p value < 0.2 were selected for multivariable logistic 
regression modelling. In a first step, multivariable sub-
models were developed for pre-existing conditions, 
animal contact, consumption of meat, meat products 
(including sausages), other food items, special diets, 
animal contact, the patient’s housing environment and 
environmental exposures. A manual backward selec-
tion procedure was used with a cut-off of p < 0.05. 
Thereafter, the submodels were combined in one 
final model using the described backward selection 
Table 1
Age group, sex and regional distribution of hepatitis E 
cases notified through the Germany surveillance system, 
cases included in the risk factor analysis and individually 
















18–34 129 15.3 28 10.4 138 11.9
35–49 243 28.8 79 29.3 312 26.9
50–64 305 36.1 112 41.5 435 37.5
≥65 168 19.9 51 18.9 274 23.6
Sex
Female 313 37.0 105 38.9 451 38.9
Male 532 63.0 165 61.1 708 61.1
Regiona
North 177 20.9 42 15.6 172 14.8
West 267 31.6 83 30.7 375 32.4
East 248 29.3 88 32.6 375 32.4
South 153 18.1 57 21.1 237 20.4
CCS: case-control study.
a Named regions included the following German states: North 
– Bremen, Hamburg, Lower Saxony, Mecklenburg-Western 
Pomerania, Schleswig-Holstein; West – Hesse, North 
Rhine-Westphalia, Rhineland-Palatinate, Saarland; East – 
Brandenburg, Berlin, Saxony, Saxony-Anhalt, Thuringia ; South 
– Baden-Württemberg, Bavaria.
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procedure. Finally, previously eliminated variables 
were reintroduced in a stepwise fashion and kept if sig-
nificantly associated with disease (p < 0.05). The vari-
able age was always forced into the respective models.
The population attributable fraction (PAF) denotes the 
proportion of cases that could be prevented by remov-
ing the respective risk factor, assuming it is causal and 
its effect was measured accurately. The PAF and the 
respective 95% confidence intervals were computed 
for all risk factors/variables of the multivariable model 
using STATA’s punafcc command [19].
Results
Study population
During the study period, 370 cases were interviewed, 
corresponding to 43.8% of all 845 cases of hepatitis E 
notified to RKI by local health authorities. Of these, 270 
(73.0%) were included in the data analysis, while 100 
(27.0%) were excluded because of travel history, miss-
ing symptoms and/or unknown date of disease onset. 
Case-patients included in the data analysis did not sig-
nificantly differ from the overall group of cases notified 
through the German surveillance system (n = 845) or 
their individually matched controls (n = 1,159) in terms 
of age group, sex or region of living (Table 1).
The proportion of hospitalised patients was 73.7% 
(199/270) and differed significantly between women 
(63.8%, 67/105) and men (80.0%, 132/165), p < 0.01. Sex 
differences were also evident regarding the frequency 
of symptoms reported by participants. Particularly, 
symptoms related to the accumulation of bilirubin, e.g. 
jaundice, were more frequent among men, while gas-
trointestinal symptoms were more prevalent among 
women (Table 2). The median duration of illness was 
34 days and the median number of work days missed 
by persons who reported missing at least 1 day of work 
(121/270, 44.8%) was 20 days. Both are minimum esti-
mates, because for patients who still had symptoms 
at the time of the interview (168/258, 65.1%), only 
the period between disease onset and interview was 
counted.
Risk factors associated with autochthonous 
hepatitis E
In the univariable analysis, 39 of 114 variables were 
positively associated (p < 0.2; OR > 1) with illness includ-
ing consumption of various meat products such as 
wild boar and pork products that had not been fully 
cooked when consumed, several kinds of sausages 
and raw vegetables but also occupational contact with 
waste water and various pre-existing conditions of the 
liver (Table 3). Other meat products and fully cooked 
items appeared to be generally protective (OR < 1), and 
the remaining items were not associated with disease 
(data not shown).
In the multivariable model, variables related to expo-
sure as well as host factors were significantly associ-
ated with disease. Among the exposures were pork 
(mOR: 3.0, 95% CI: 1.4–6.6) and wild boar meat (mOR: 
3.7, 95% CI: 1.1–12.4) that was not fully cooked at 
the time of consumption, but also sausages that are 
intended to be eaten without further preparation 
Table 2
Proportion of hospitalisation and frequency of symptoms among autochthonous and symptomatic cases of hepatitis E by 
















Hospitalised 199/270 73.7 67/105 63.8 132/165 80.0 p < 0.01
Fever > 38 °C 84/265 31.7 34/103 33.0 50/162 30.9 NS
Abdominal pain 97/269 36.1 48/105 45.7 49/164 29.9 p < 0.01
Nausea 129/269 48.0 60/105 57.1 69/164 42.1 p < 0.05
Vomiting 65/267 24.3 30/102 29.4 35/165 21.2 NS
Diarrhoea 71/268 26.5 30/104 28.9 41/164 25.0 NS
Loss of appetite 177/269 65.8 77/105 73.3 100/164 61.0 p < 0.05
Headache 102/268 38.1 47/104 45.2 55/164 33.5 NS
Fatigue 218/270 80.7 84/105 80.0 134/165 81.2 NS
Upper or lower extremity pain 108/265 40.8 44/104 42.3 64/161 39.8 NS
Generalised pruritus 117/267 43.8 44/104 42.3 73/163 44.8 NS
Jaundice (eyes) 145/269 53.9 42/105 40.0 103/164 62.8 p < 0.01
Jaundice (skin) 128/266 48.1 36/102 35.3 92/164 56.1 p < 0.01
Dark urine 206/267 77.2 66/105 62.9 140/162 86.4 p < 0.01
Clay-coloured stool 143/263 54.4 48/103 46.6 95/160 59.4 p < 0.05
NS: no statistically significant association.
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Table 3a
Risk factors for symptomatic hepatitis E virus infection in persons without travel history (univariable and multivariable 

















95% CI PAF 95% CI
Consumption of meat
Minced porka 42/269 15.6 130/1,157 11.2 1.6 1.1–2.4 NA
Minced pork and beef 
(mix) a 56/266 21.1 197/1,152 17.1 1.4 0.97–1.94 NA
Pork (e.g. roast) 143/268 53.4 529/1,159 45.6 1.4 1.03–1.81 NA
Pork (e.g. roast)a 16/263 6.1 21/1,158 1.8 3.9 1.9–7.9 3.0 1.4–6.5 0.04 0.01–0.07
Wild boara 8/265 3.0 10/1,135 0.9 3.3 1.2–8.6 3.7 1.1–12.4 0.02 0–0.04
Rabbita 2/265 0.8 2/1,135 0.2 3.6 0.5–23.5 NA
Pork livera 12/263 4.6 14/1,135 1.2 4.3 1.9–10.1 5.3 1.8–15.7 0.04 0.01–0.07
Pork offal (excluding 
liver)a 2/259 0.8 1/1,135 0.1 11.2 0.7–171.2 NA
Beef livera 6/265 2.3 11/1,134 1.0 2.6 0.9–7.7 NA
Beef offal (excluding 
liver)a 2/264 0.8 1/1,135 0.1 8 0.7–88.2 NA
Home-butchered meat 15/268 5.6 40/1,153 3.5 1.8 0.96–3.20 NA
Consumption of meat 
products
Spreadable sausages 
made of raw meat (e.g. 
Teewurst, Mettwurst)
94/268 35.1 307/1,158 26.5 1.5 1.1–2.0 NA
Raw ham 165/270 61.1 600/1,158 51.8 1.4 1.1–1.0 NA
Cooked cured products 
(eg., cooked ham) 109/269 40.5 349/1,159 30.1 1.6 1.2–2.1 NA
Boiled sausage 141/269 52.4 496/1,158 42.8 1.5 1.1–2.0 NA
Sülzwurst (sausage 
containing meat jelly) 24/269 8.9 73/1,157 6.3 1.6 0.95–2.59 NA
Liver sausage or liver 
pâté 114/270 42.2 324/1,159 28.0 1.9 1.5–2.6 2.1 1.5–3 0.24 0.12–0.33
Boiled sausage (e.g. 
frankfurter, wiener) 97/267 36.3 282/1,159 24.3 2.0 1.4–2.7 1.9 1.3–2.7 0.18 0.08–0.26
Consumption of other 
food items
Raw vegetables 222/269 82.5 805/1,157 69.6 2.0 1.4–2.8 1.9 1.3–2.9 0.39 0.17–0.56
Animal contact
Dogs 58/267 21.7 204/1,159 17.6 1.3 0.9–1.8 NA
Cats 65/265 24.5 221/1,159 19.1 1.4 1.01–1.89 NA
Domestic pigs 4/265 1.5 8/1,159 0.7 2.2 0.7–7.5 NA





4/264 1.5 28/1,158 2.4 0.7 0.2–2.0 NA
Contact with waste 
water (occupational) 20/267 7.5 18/1,159 1.6 5.2 2.7–10.1 5.5 2.1–13.9 0.06 0.02–0.1
CI: confidence interval; HBV: hepatitis B virus; HCV: hepatitis C virus; mOR: matched odds ratio; PAF: population attributable fraction; NA: not 
applicable (variable is not part of the final multivariable model).
a Consumed raw, rare or otherwise not fully cooked.
Only variables with an adjusted odds ratio (aOR) > 1 and a p value < 0.2 in the univariable analysis are shown.
5www.eurosurveillance.org
(ready-to-eat), such as liver sausage or liver pâté 
(mOR: 2.1; 95%CI: 1.5–3.0) and frankfurter/wiener 
types (mOR: 1.9; 95%CI: 1.3–2.7). Additional exposures 
associated with disease were consumption of raw veg-
etables (mOR: 1.9, 95%CI: 1.3–2.9) and occupational 
contact with waste water (mOR: 5.5, 95% CI: 2.1–13.9). 
Among host factors were various pre-existing condi-
tions of the liver, diabetes mellitus and gastrointesti-
nal diseases other than Crohn’s disease or ulcerative 
colitis (Table 3). The highest PAFs were found for liver 
pâté or liver sausage, boiled sausages (i.e. frankfurter 
or wiener) and raw vegetables.
Among cases, 1 of 266 (0.4%) followed a diet avoiding 
the consumption of pork or pork products (vegetarian, 
vegan, halal or kosher), compared with 67 of 1,155 con-
trols (5.8%). In a single risk analysis, dietary exposure 
to pork was significantly associated with hepatitis E 
(mOR = 17.4; 95% CI: 2.4–127.9; p < 0.01). The PAF was 
93.9% (95% CI: 0.56–0.99). Cases and controls did not 
differ in following any other special diet (3.5% cases vs 
3.4% controls).
From disease onset to diagnosis
Among 239 of 261 (91.6%) cases with available infor-
mation, a positive serological test result was obtained 
and 42 (16.1%) were positive by PCR. From symptom 
onset to diagnosis of hepatitis E as reported by cases, 
it took a median of 19 days (interquartile range (IQR): 
12–29 days). Cases reported first visit to a physician 
after a median of 5 days of symptoms (IQR: 2–12). In 
the majority of cases (218/254, 85.8%), physicians 
took blood samples at this first visit or the day there-
after. Median number of days between visit and blood 
sampling for all patients was 0 days (IQR: 0–0), but 
it took another 9 days (median, IQR: 5–16 days) until 
the diagnosis of hepatitis E was made. Eighty-five per 
cent of cases (222/260) reported seeing two or more 
practitioners before receiving a diagnosis of hepati-
tis E, 23.8% (62/260) saw three or more. Of all cases 
included in the data analysis, 168 (62%) reported 
receiving a preliminary diagnosis from their physician 
before the diagnosis of hepatitis E was made, includ-
ing: hepatitis of unknown origin (28.6%, n = 48), viral 
hepatitis (17.9%, n = 30), cholecystitis (25.0%, n = 42), 
drug-induced hepatitis (10.7%, n = 18), gastrointestinal 
disease (8.9%, n = 15) and autoimmune hepatitis (7.1%, 
n = 12). Before the diagnosis was made serologically or 
by PCR, cases reported receiving the following inves-
tigations: ultrasound (91.5%, n = 246), stool (11.5%, 
n = 31) or urine diagnostics (17.4%, n = 46), CT (11.5%, 
n = 31), MRT (8.9%, n = 24), conventional X-ray (9.3%, 
n = 25), gastro- or colonoscopy (19.6%, n = 53), biopsy 

















95% CI PAF 95% CI
Pre-existing conditions
Diabetes mellitus 46/268 17.2 99/1,157 8.6 2.3 1.5–3.4 3.3 1.8–5.8 0.11 0.06–0.17
Autoimmune diseases 27/261 10.3 68/1,141 6.0 1.9 1.2–3.1 NA
Malignant diseases 22/267 8.2 66/1,154 5.7 1.4 0.8–2.4 NA
Gastrointestinal disease 
(not ulcerative colitis or 
Crohn‘s disease)
46/267 17.2 77/1,154 6.7 2.9 1.9–4.3 2.4 1.4–4.2 0.11 0.04–0.17
Congenital diseassses 8/268 3.0 15/1,152 1.3 2.3 0.99–5.55 NA
Allergies 100/266 37.6 355/1,153 30.8 1.4 1.01–1.80 NA
Acid-reducing drugs 60/268 22.4 185/1,155 16.0 1.5 1.1–2.1 NA
Hepatitis B 5/265 1.9 3/1,155 0.3 10.0 1.9–51.8 29.2 4.9–175.3 0.02 0–0.03
Chronic liver infections 
(non-HBV/HCV) 7/265 2.6 6/1,155 0.5 5.4 1.6–18.7 NA
Chronically elevated 
liver enzymes 24/270 8.9 30/1,151 2.6 4.4 2.3–8.3 6.1 2.9–12.6 0.07 0.04–0.11
Fatty liver disease 
(non-alcoholic) 16/270 5.9 34/1,151 3.0 1.9 1.04–3.47 NA
Fatty liver disease 
(alcoholic) 7/270 2.6 5/1,151 0.4 9.1 2.2–36.8 NA
Liver cirrhosis 9/270 3.3 2/1,151 0.2 36.0 4.5–285.4 34.1 3.1–372.2 0.03 0.01–0.06
Liver diseases, other 10/270 3.7 25/1,151 2.2 1.9 0.9–4.3 NA
CI: confidence interval; HBV: hepatitis B virus; HCV: hepatitis C virus; mOR: matched odds ratio; PAF: population attributable fraction; NA: not 
applicable (variable is not part of the final multivariable model).
a Consumed raw, rare or otherwise not fully cooked.
Only variables with an adjusted odds ratio (aOR) > 1 and a p value < 0.2 in the univariable analysis are shown.
Table 3b
Risk factors for symptomatic hepatitis E virus infection in persons without travel history (univariable and multivariable 
logistic regression analysis), Germany, January 2012–2014 (n = 1,429)
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Discussion 
To our knowledge, this is the largest population-based 
study on risk factors for acute hepatitis E in Europe, 
involving 270 cases representative of all notified hepa-
titis E cases in the study period and over 1,100 closely 
matched controls. All cases included in our study had 
acute, symptomatic hepatitis E, setting it apart from 
serological studies. It has been suggested the inocu-
lum required to cause symptomatic HEV infection is 
1,000-fold higher than that leading to asymptomatic 
seroconversion. Thus, exposures relevant for sympto-
matic and asymptomatic infection may differ enough to 
be considered separately [20,21].
We found that risk factors for autochthonous hepatitis 
E in Germany include but are not limited to the con-
sumption of undercooked pork liver, pork and wild boar 
meat. The consumption of two popular, ready-to-eat 
pork products, liver sausage or pâté and frankfurter/
wiener type sausage, were significantly associated with 
acute hepatitis E and, in our final regression model, 
23.6% and 17.6% of acute hepatitis E was attributable 
to these two vehicles, respectively.
Liver sausage and frankfurter/wiener type sausages 
available in Germany are cooked or parboiled during 
production and are generally assumed to be free of 
intact virions able to cause infection [18]. These prod-
ucts have thus to be distinguished from products that 
are expected to be cooked by the consumer before 
consumption, such as the figatellu raw-liver sausage 
implicated in several outbreaks in France [2,3] or the 
sausages from a major supermarket chain implicated 
in a case-control-study in the United Kingdom [4].
Previous studies have detected HEV genome (RNA) in 
various commercial pork products such as in 22% of 
liver sausages bought in supermarkets in Berlin, 47% 
of pork pâtés sampled in Canada or 4% of pork livers 
bought in butcher shops and supermarkets in southern 
Germany [18,22,23]. Cell culture models, which could 
distinguish between non-infectious RNA-fragments 
and infective virus, are not yet generally available. 
Thus, epidemiological findings are needed to help 
assess these products actual risk to the consumer. Our 
results indicate that HEV is insufficiently inactivated 
during common sausage production methods. A study 
applying a bioassay showed that HEV is resistant to 
heat and recommended that pork, pork products as 
well as meat products from wild animals such as boar 
be heated to ≥ 71 °C for a duration of at least 20 min to 
inactivate HEV [17].
Ready-to-eat pork products have also been found to be 
a risk factor in England, where the consumption of pork 
pie, sausages and ham were significantly associated 
with infection [4]. Pork liver pâtés have been implicated 
in an outbreak of hepatitis E in Australia [24]. Food 
habits, preferences and available food items vary enor-
mously even between European countries and more 
research is needed to determine risk factors common 
and unique to different countries and populations.
The association between the consumption of raw veg-
etables and disease in our study was unexpected. In 
the EU and most other countries, the use of pig manure 
is closely regulated to avoid harm to the consumer. 
Moreover, lettuce, which is grown, marketed and con-
sumed similarly to raw vegetables, was not associated 
with disease in our study. We thus regard this finding 
as possibly accidental and warranting further research.
The significant difference in the proportion of persons 
avoiding pork or pork products for religious or other 
reasons among cases (0.4%) and matched controls 
(5.8%) and the striking population attributable frac-
tion of 93.9% lends another line of evidence for the 
consumption of pork and pork products as the major 
risk factor for acquiring zoonotic (genotype 3) hepatitis 
E in Germany. It also argues against a high contribution 
of vegetarian food items to the burden of infections.
In addition to risk factors related to exposure to HEV, 
several pre-existing conditions were strongly associ-
ated with hepatitis E. These included pre-existing liver 
disease which might predispose hepatitis E patients to 
severe courses of disease [12,25,26], diabetes mellitus 
which likely impairs hepatocyte-regenerating capacity 
[27] and (non-inflammatory) gastrointestinal diseases, 
which have, not previously been reported as associ-
ated with hepatitis E. The nature of the association of 
the latter is unknown but could be related to intake 
of acid-reducing drugs (e.g. proton pump inhibitors) 
which was reported by more than half of the patients 
with pre-existing non-inflammatory conditions of the 
gastrointestinal system in our study.
Clinical aspects
Our data shows that acute hepatitis E is the source of 
considerable morbidity and cost, with 73.7% of case-
patients hospitalised and a median of 20 days of missed 
work among those employed. This is considerably more 
than in German hepatitis A patients interviewed in the 
framework of an enhanced surveillance study, where 
46% were hospitalised and those employed missed a 
median of 6 days of work [28]. The incidence of hepa-
titis E in our study was more than twice as high as the 
incidence of hepatitis A in Germany in 2016 [14].
While there is no sex difference in terms of HEV sero-
prevalence in Germany [15], 60% of cases notified 
between 2012 and 2016 were diagnosed in men [14]. 
It is unclear whether this is due to sex-specific suscep-
tibility [29], differences in the prevalence of additional 
risk factors for developing clinical hepatitis (i.e. pre-
existing liver conditions) [25], differential diagnostic 
work-up of disease in men and women or whether men 
are exposed to higher alimentary doses of HEV com-
pared with women and are thus more likely to develop 
symptoms. Our data show statistically significant dif-
ferences in the clinical presentation and hospitalisation 
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proportion of acute hepatitis E in men and women, sug-
gesting that there are indeed sex-specific differences 
in disease development.
Diagnosing hepatitis E in a patient should be straight-
forward. There are several serological and PCR-based 
assays on the market and available to health practi-
tioners in Germany through professional laboratories 
[30]. Our data shows that physicians usually sus-
pected (viral) hepatitis and took a blood sample at 
the patient’s first visit. However, there were often long 
delays before the diagnosis of hepatitis E was made. 
It seems that hepatitis E was not considered as a rel-
evant differential diagnosis or was only considered 
after other causes were ruled out. Hepatitis E has long 
been regarded as a rare, imported disease [31] and in 
this situation it appeared to be economical to initially 
test for the more common hepatitis A, B and C virus, 
cytomegalovirus and Epstein–Barr virus infection 
in patients with hepatitis or elevated liver enzymes. 
Today, hepatitis E may be the most frequently diag-
nosed viral cause of hepatitis in patients seen by medi-
cal specialists and general practitioners [32] and many 
laboratories have consequently included HEV in their 
routine hepatitis work flow. Still, recent data shows 
that patients with acute hepatitis caused by HEV are 
frequently misdiagnosed as having drug-induced liver 
injury or auto-immune hepatitis [33,34]. The high pro-
portion of patients in our study who received invasive 
diagnostic procedures (gastro- or colonoscopy: 19%; 
biopsy of the liver: 17%) or visited more than one phy-
sician before hepatitis E was diagnosed, suggests that 
practitioners failed to consider HEV infection as a dif-
ferential diagnosis right away.
Limitations
Due to the high lifetime prevalence of symptomatic or 
asymptomatic HEV infection in Germany [15], we have 
to assume that several control persons were seroposi-
tive at the time of the study and thus were not sus-
ceptible to HEV exposure in the 2 months before the 
interview. This likely leads to an underestimation of 
odds ratios (ORs) of relevant risk factors or that a risk 
factor remains undetected. ORs reported in our study 
should thus be seen as a conservative estimate of the 
true ORs (or risk).
An important potential source of bias in all case–con-
trol studies is differential recall between cases and 
controls. While cases were interviewed about expo-
sures 2 months before symptom onset, we chose the 
2 months before the interviews for controls to adjust 
for the more vivid memory of the period before disease 
onset in cases.
Conclusions and recommendations
Our population-based study suggests that the con-
sumption of pork and pork products is the main risk 
factor for symptomatic hepatitis E infections acquired 
in Germany. This specifically includes products that are 
intended to be consumed without further preparation 
by the consumer (such as liver sausage). The study 
expands on the role of host factors that play a consid-
erable role in determining who develops clinical hepati-
tis E and who remains asymptomatic after an exposure 
to HEV, such as pre-existing liver disease or diabetes 
mellitus.
We recommend educating consumers that pork and 
offal should always be thoroughly cooked before con-
sumption. Further epidemiological and virological 
studies are needed to confirm the role of cooked or 
parboiled sausages and raw vegetables as a possible 
risk factor for hepatitis E and to investigate sources 
of contamination and methods of virus detection and 
inactivation. In view of accumulating evidence of com-
mercial pork products as one of the main risk factors 
for hepatitis E, production methods should be reviewed 
and possibly adjusted to ensure inactivation of HEV. 
Opportunities to reduce HEV in commercial pig herds 
should be explored. Physicians need to be aware that 
testing for hepatitis E is indicated in all cases of clinical 
hepatitis in order to prevent delays in diagnosis.
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